Skip to main content

Table 2 Contexts, possible mechanisms and outcomes of PPIE in implementation of evidence-based guidance for MSK conditions

From: Patient and public involvement in implementation of evidence-based guidance for musculoskeletal conditions: a scoping review of current advances and gaps

First Author /Year of publication

PPIE activities

Context for PPIE involvement

Levels of PPIE

Outcomes of PPIE involvement

Probable mechanisms for effectiveness of PPIE in contextualisation and implementation

Additional notes/ Other relevant findings

Blackburn 2017 [19]

Design/planning: 1. steering guideline implementation project

2. evaluation of guideline implementation

Implementation in clinical practice

Guideline monitoring/quality improvement, and implementation for shared decision making, patient education and empowerment

Shared partnership and leadership

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: NR

Guideline uptake/adherence: NR

healthcare organisation/practical issues: international collaboration of PPIE within implementation projects

Contextualisation

1. Patient Champion as part of guideline implementation project steering committee

2. PPIE support alongside involvement e.g., in development of a set of glossary of terms to support the involvement of patient panel members throughout the project

Implementation

Emphasis not only on language translation but also cultural adaptation of patient information resources

Abstract only- lacking actual details and description of PPI in every stage

An example of PPI in planning guideline implementation strategy

Reports consideration for factors that may affect context such as settings, views of target users and some shared learnings with relevant health care organisation

Campbell 2018 [20]

Delivery phase: cultural adaptations and contextualisation of a lay version of OA guidance and recommendations

Implementation for shared decision making/patient education/empowerment implementation in clinical practice

Shared partnership and leadership

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: feasibility and effectiveness of patient CoPs

Guideline uptake/adherence: NR

Healthcare organisation/Practical issues: Implementation of OA guidelines—The production and dissemination of a new resource: culturally adapted, consistent and accurate patient information booklet to aid clinical practice and consequently patient outcomes

Contextualisation

Patient voice in language, images, content

Implementation

1. PPIE leadership and ownership through CoPs and wider engagement with local patient organisations. 2. Wider engagement with other stakeholders could have enhanced uptake and implementation in practice. 3. Cultural adaptations and considerations for how local health systems works. Nb: output was targeted and localised to the different health systems in the countries involved

Elements of successful PPIE: consistency check with national guidelines; shared learning across countries; freedom of each CoP to adopt a process appropriate to their specific context

Offers opportunity for PPI to challenge and evaluate

Includes drive to scale up and share learnings around guideline implementation

De Keyser 2015 [21]

Delivery phase: development of patient version

Implementation for shared decision making/patient education/empowerment

Involvement (process)

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: NR

Guideline uptake/adherence: NR

healthcare organisation/Practical issues: NR

Contextualisation

1. Training of PPIE participants and partners to ascertain understanding and familiarity with original EULAR recommendations

2. Collaboration with healthcare professionals to guarantee quality and ensure translations are a correct reflection of the original documents

Implementation

Available resources such as: Link with EULAR, expert academics and researchers?

Abstract only- lacking actual details and description of PPI in every stage

Possible link to development of guideline implementation strategy

De Wit 2011 [22]

Delivery phase: development of patient version

Implementation for shared decision making/patient education/empowerment

Involvement (process)

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: NR

Guideline uptake/adherence: An easy tool to facilitate uptake of T2T recommendations in practice (among HCPs)

healthcare organisation/Practical issues: enhance shared understanding and ensure smooth processes organisation of RA treatment and monitoring according to recommendations. Outcome of current process: “Participants noticed that the T2T recommendations, like the EULAR/ASAS recommendations, have a strong focus on body functions and structures, while patient-centred care in rheumatology also requires, besides medical expertise and monitoring, non-pharmacological and psychosocial support”

Contextualisation

PPIE involvement had been preceded by pre-work among a core group:—four members of the international T2T Steering Group, including one patient representative), produced a draft version of the T2T recommendations in lay language which was discussed, amended and reworded during a 1-day consensus meeting with nine RA patients and moderated by two members of the core group (a patient and researcher). Also, 5 of 9 participants had been previously involved in the consensus meeting leading to the development of T2T recommendations.—Continuity or overfamiliarity with content affect output?

Implementation glossary of terms in lay language was also developed to accompany patient version recommendations

Product developed by experienced patient representatives fluent in English. No report of validation among lay patients. Translation into different languages, testing, and processes for dissemination in different countries were agreed as subsequent next steps

study described details of PPI participants recruitment and selection as well as detailed level/process of involvement. Missing detail on development stage highlighted during contextualisation

Examples of scale up and shared learnings but may have missed opportunity for PPI contributions to define and confirm what implementation should be

Dziedzic et al. 2018, 2014 [23, 24], Blackburn 2016 [25]

Design, delivery, and evaluation

Implementation in clinical practice

Also implementation for shared decision making/patient education/empowerment; Reference to another quality indicator (clinician/research led) in Norway as a basis for comparison and content validity

Shared partnership and leadership

Patient Health outcomes: There were no statistically significant differences in SF-12 PCS: mean difference at the 6-month primary endpoint was − 0.37 (95% CI − 2.32, 1.57)

Empowerment/enablement/self-efficacy:

improvement in patient enablement suggests a beneficial effect of the intervention on the capacity of patients for self-management—one of the targets of NICE core guidance

Guideline uptake/adherence: Uptake of core NICE recommendations by 6 months was statistically significantly higher in the intervention arm compared with control: e.g., increased written exercise information, 20.5% (7.9, 28.3)

healthcare organisation/Practical issues: Identifying important and relevant quality indicators of OA in primary care consultations from a patient’s perspective. The OA QI (UK) was developed to assess the uptake of treatment recommended by NICE and complements the new NICE Quality Standards of Care for OA. The development of two OA indicator questionnaires (quality indicators validated for Norwegian OA and UK consultations) coincidental but led to further research to compare patient reported OA QIs across European countries

Contextualisation

research team met with RUG members to co-produce the OA QI (UK) questionnaire. Discussion meetings were facilitated by the Centre’s PPI Support Worker/Coordinator, the MOSAICS study Chief Investigator and a trial coordinator. The PPI Support Worker/Coordinator provided a key role by attend the meetings with RUG members to provide assistance and support, prior, during and after meetings. Discussion notes from the meetings were recorded on flip charts and in meeting minutes. Following each meeting, a summary of the outcomes and decisions written in plain English was sent to the RUG members to acknowledge their contribution and verify that all views had been captured. RUG members were also given the opportunity for further comment at the start of the next meeting

Implementation

The discussion groups took place over a three-year period from 2009–2012. extended gaps between meetings regarding the OA QI (UK) development, the timings of the meetings were governed by the study timeline. However, RUG members were provided with feedback of the meeting and given the opportunity to comment. This process built upon existing working relationships and trust between the RUG and researchers

NB: RUG membership was not greatly diverse, in terms of age, ethnicity, and physical abilities. While obtaining a range of perspectives is the objective of PPI in research and not necessarily ‘representativeness’, it is possible however that the OA QI (UK) does not cover the full range of quality indicators relevant to the population of patients with OA. Nevertheless, the sequential and iterative development of the OA QI (UK) allowed the researchers and RUG members to review and critique earlier suggestions made by the RUG

Targeted approach to guideline implementation. Strategy developed close to guideline development though not by the development group. PPI contribution along the continuum included contextualisation, evaluation, refining, scale up and shared learnings

Kiltz 2010 [26]

Delivery phase: Translation and brief validity of translations

Guideline impact evaluation

Shared partnership and leadership

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: NR

Guideline uptake/adherence: NR

healthcare organisation/Practical issues: NR

Contextualisation

Patients discussed language, content and evaluated proposed recommendations

Implementation NR

Limited detail but article presents a case of PPI in scale up of guideline implementation products

The report may also have missed opportunity to capture PPI contributions in defining the specific implementation strategy

McCaul 2020 [27]

Delivery phase: cultural adaptations, contextualisation of guideline recommendations

Guideline adaptation and contextualisation in a resource-constrained setting

Consultation

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy:

Guideline uptake/adherence: NR

healthcare organisation/Practical issues: access to funding and dedicated human resources were a significant challenge to adapting contextualised recommendations in intended setting

Contextualisation

Stakeholders evaluated proposed recommendations

Implementation

An end-user document with an implementation plan is currently being developed

Key learnings revolved around navigating funding and human resource challenges, whereas opportunities include addressing guideline training gaps and investing in strengthening adaptation and contextualisation of guideline recommendations through stakeholder engagement for efficient guideline development and enhanced uptake

PPI contributions indistinct though involvement was aimed at addressing a mix of service delivery (care pathway) and clinical content too

Impact of PPI on guideline contextualisation could not be assessed. Missed opportunity for PPI contributions to define and confirm what implementation should be

Özgöçmen 2009 [29]

Delivery phase: Translation and patient evaluation

Guideline impact evaluation

Involvement (process)

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: NR

Guideline uptake/adherence: NR

healthcare organisation/Practical issues: possible changes in the applications of drug recommendations were referenced from a linked study due to differences in the legislation and reimbursement institutions between European countries

Contextualisation

Patients discussed language, content and evaluated proposed recommendations

Implementation NR

PPI centred at latter end for scaling up guideline dissemination product

O'Sullivan 2017 [28]

Design and delivery-phases

Guidelines development

Consultation

Patient Health outcomes: NR

Empowerment/enablement/self-efficacy: NR

Guideline uptake/adherence: NR

healthcare organisation/Practical issues: NR

Contextualisation

Patients involved in development of guidance but unclear how and to what extent

Implementation NR

The project team used a professional graphic designer to help with the graphic and formatting elements of the project but found this stage demanding and time-consuming? Challenges with processes and supporting PPI were highlighted

Patient voice indistinct. PPI contributions were targeted at later end for scaling up guideline dissemination product

Impact of PPI on guideline contextualisation could not be assessed

Swaithes 2020 [30]

Design/planning: input into design and interpretation of findings

Implementation in clinical practice

Involvement (process)

Aided formative evaluation and capturing mechanisms involved in implementation of guideline recommendations

Contextualisation

NA

Implementation

Expertise and lived experience maximised to inform formative evaluation and capture nuances and context-based factors influencing OA guideline implementation

Focussed PPI input into capturing implementation processes and future learning. Public contributors were part of an established and experienced group for lay involvement in knowledge mobilisation

Refining and evaluating PPI in guideline implementation

  1. PPI Patient and Public Involvement, PPIE Patient and Public Involvement and Engagement, CoP Communities of Practice, OA Osteoarthritis, NICE National Institute for Clinical Excellence, ASAS Assessment in Spondyloarthritis International Society, EULAR European League Against Rheumatism, RA Rheumatoid Arthritis, HCPs Health Care Professionals, RUG Research User Group, QI Quality Indicator, T2T Treat to target